Silver Book Fact

Gains in healthy years of life and social value from cancer R&D

Fact image

Lakdawala, D, E Sun, A Jena, C Reyes, D Goldman, et al. An Economic Evaluation of the War on Cancer. J Health Econ. 2010; 29(3): 333-46. http://www.sciencedirect.com/science/article/B6V8K-4YH567G-1/2/88c88fbdd7f57d9fe08803ec85397bc0

Reference

Title
An Economic Evaluation of the War on Cancer
Publication
J Health Econ
Publication Date
2010
Authors
Lakdawala, D, E Sun, A Jena, C Reyes, D Goldman, et al.
Volume & Issue
Volume 29, Issue 3
Pages
333-46
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value

Related Facts

  • Breast cancer incidence rates in women decreased 3.5% per year from 2001-2004, the first decrease observed in 20 years.  
  • Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349…  
  • Because of advances in treatment, the 5-year survival rate for people with actue lymphocytic leukemia has increased from 38% in 1974-1976 to 65% in 1995-2001.  
  • Cancer death rates for all races/ethnicities and both sexes combined decreased by 2.1% per year from 2002-2004, nearly twice the annual decrease of 1.1% per year from 1993-2002.